In total, 5,251 discretized criteria were extracted from 216 protocols. The most frequent criterion was previous chemotherapy/biologics (17%). The multilabel SVM demonstrated a pooled accuracy of 75%.
A number of solutions have been proposed to overcome these barriers and increase trial enrollments. Some centers practice just-in-time trial activation, which minimizes administrative overhead by ...